Rheumnow

ACR21   Day 1 Recap Panel with Drs. Cush, Najm, Mehta, Yusof, Castillo, Conway

The PROOF Study in AxSpA: Dr. Sheila Reyes Management of Pain in Spondyloarthritis: Dr. Antoni Chan Pregnancy complications in Ankylosis Spondylitis: Dr.Olga Petryna JAKi For Refractory Still’s Disease: Dr. Olga Petryna Sinusitis and Pharyngitis and RA with Dr.  Richard Conway Cognitive Function and Rheumatoid Arthritis: Dr. Akhil Sood Interviews Dr. Elena Myasoedova Serum Biomarkers to Distinguish Radiographic Progression in PsA with Dr.  Robert Chao

Preventive Window of Opportunity in RA? Dr. Aurelie Najm Iberdomide for Lupus: Dr. Kathryn Dao Increased Risk of MACE in Lupus After Noncardiac Surgery: Dr. Kathryn Dao Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade Complications of Covid19 in Lupus: Dr. Kathryn Dao Dose Tapering of TNFi in AxSpA: Dr. Antoni Chan Dr. Yuzaiful Yusof: Factors Associated with Poor Vaccine Response in Rituximabe-treated Patients

What's Cool and Hot in Vasculitis: Dr. Janet Pope ARIAA Study - Abatacept Reverses ACPA+ Subclinical Arthritis: Dr. Jack Cush MRI Imaging in RA and SpA: Dr. Sheila Reyes Sick Leave, Work Disability in Patients with AxSpA: Dr. Mrinalini Dey PsA Perspectives - IL-23: Dr. Eric Ruderman Patient Clustering Based on Multimorbidity Patterns in RA: Dr. Mrinalini Dey and Dr. Bryant England

COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao AxSpA: Geographic Prevalence Association with HLA-B27: Dr. Rachel Tate What I'm Looking Forward to at ACR: Dr. Arthur Kavanaugh Fibromyalgianess Glucocorticoid Persistence in RA Patients: Dr. Sheila Reyes

SLE Panel-Learning about Lupus at ACR 2021

Opening Ceremony, Keynote Lecture and Year in Review Discussants:  Drs. Jack Cush, Sheila Reyes, Rachel Tate & Kathryn Dao

QD153 - Serologically Active, Clinically Quiescent SLE QD154 - Paradoxical Psoriasis   QD155 - Scary Steroids QD156 - How I Treat Rheumatoid Arthritis

Dr Cush reviews the news and kicks off ACR21 learning and how to take in the annual meeting

QD148 - Severe Arthritis Numbers and Associations QD149 - The Thyroid Lump   QD150 - Alopecia Rules QD151 - Half Baked Blogs QD152 - Who is Immunosuppressed? 

Dr. Jack Cush reviews the news and journal articles from the past week and discusses parent-child rheumatologists pairs

Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

Dr. Jack Cush reviews the FDA approvals, news and the latest journal articles from the past week on RheumNow.com

Dr Jack Cush reviews the news and journal reports from this past week on RheumNow.com; plus questions & cases from viewers in (#ACA) Ask Cush Anything.

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections during fetal life or childhood did not increase risk of JIA. #RheumNow https://t.co/Md0zBm5Txl Alendronate may protect against type 2 Diabetes. Data from National Danish Patient Registry, presented at the EASD meeting compared 160k T2DM & 500k controls, T2DM following alendronate adjusted OR=0.64; 0.62-0.66; ⋗8yrs OR=0.47 https://t.co/RYEZodUZtv Analysis of 508 #RA pts (over 10 yrs) in the BeST study shows joint swelling at baseline resulted in half w/ re-swelling later and significantly increased risk of same joint

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or steroid prescribing between visit types https://bit.ly/39wWoQ6 Encouraging DBRPCT of Rituximab in #PMR: 116 screened, 49 enrolled, 47 completed: 23 on RTX vs 24 on PBO. Steroid-free remission at 21 wks seen with 11/23 (48%) RTX pts vs 5/24 (21%) on PBO (p=0·049). Infusion Rxns: 10 RTX vs 3 PBO); 1 SAE (PE) on RTX https://bit.ly/3lSI0rj Pregnancies exposed to ixekizumab (from Eli Lilly Global Safety Database) found 193 pts with psoriasis, PsA, or axSpA who were IXE exposed. Live births reported for 53.8 and 61.1% of known

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com Metanalysis of JAK inhibition (tofacitinib & ruxolitinib) in alopecia areata - 12 studies, 346 Pts, Rx success (using SALT50 resp) was 66%, not influenced by age, sex, subtype. Alopecia recurrence seen w/in 3 mos of JAK D/C (in74%) https://t.co/CBSy4Kci80 Population study shows risk of H. Zoster in adults to be high among bDMARD and CTX, also increased w/ AZA and HCQ but not MTX SSZ or LEF users. Data from 254065, 1,826311 Pt-Yrs F/U, 6295 new DMARD users, 17024 incident HZ https://t.co/1TeOAWN9LB MMWR reports that during the COVID Delta variant era, Vaccination against COVID-19: - Reduces risk of COVID-19 infection 5X - Reduces risk of COVID-19 Hospitalization ⋗10X - Reduces risk of COVID-19 DEATH 1

Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

Dr. Jack Cush is joined by Drs. Kathryn Dao (Dallas), Rachel Tate (Palm Beach), William Shergy (Huntsville) and Jeffrey Sparks (Boston)

Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com